semaglutide and hormone replacement therapy Can support better weight loss outcomes with GLP-1 medications? Emerging research suggests it might. A 2024 study found that postmenopausal women who used hormone therapy (HRT) alongside a GLP-1 GLP-1 Medication + Bioidentical Hormone

The NAION docket has grown from 86 cases in May to 146 cases in July

Inositol-mediated activation of PI3K/Akt signaling is believed to play a role in hepatic lipid metabolism and gluconeogenesis

It produces glutathione, an antioxidant that comes in to neutralize free radicals

What topics do you want to explore

This integrated approach supports a more informed conversation about whether compounded semaglutide aligns with your individual health profile

Retatrutide holds no UK marketing authorisation and may only be supplied on a named-patient basis via the MHRA 'Specials' framework, where a registered prescriber takes personal responsibility for its use